Tobias Else Selected Research

Tobias Else Research Topics

Disease

27	Neoplasms (Cancer) 08/2022 - 04/2008
14	Adenoma (Adenomas) 01/2022 - 01/2016
9	Paraganglioma (Paragangliomas) 01/2022 - 08/2014
9	Adrenocortical Carcinoma 11/2020 - 02/2014
9	Hyperaldosteronism (Conn Syndrome) 08/2020 - 01/2016
6	Pheochromocytoma 01/2022 - 11/2017
4	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 01/2009
3	Cushing Syndrome 01/2022 - 04/2014
3	Disease Progression 11/2021 - 04/2014
3	von Hippel-Lindau Disease (von Hippel Lindau Disease) 11/2021 - 08/2015
2	Hypoxia (Hypoxemia) 11/2021 - 08/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 01/2018
2	Hypertension (High Blood Pressure) 01/2021 - 02/2020
2	Multiple Endocrine Neoplasia Type 1 11/2020 - 12/2017
2	Carcinogenesis 03/2016 - 10/2009
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 08/2022
1	Hemangioblastoma 11/2021
1	Dizziness (Lightheadedness) 11/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Osteoporosis 01/2021
1	Abdominal Obesity 01/2021
1	Diabetes Mellitus 01/2021
1	Li-Fraumeni Syndrome 11/2020
1	Pseudohypoaldosteronism 02/2020
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2020
1	Essential Hypertension 02/2020
1	Liddle Syndrome 02/2020
1	COVID-19 01/2020
1	Birt-Hogg-Dube Syndrome 07/2019
1	Tuberous Sclerosis (Bourneville's Disease) 07/2019
1	Angiomyolipoma 07/2019
1	Hereditary leiomyomatosis and renal cell cancer 07/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Leiomyomatosis 01/2018
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 12/2017
1	Gastrinoma 12/2017
1	Hyperplasia 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2017
1	Familial Hyperaldosteronism 01/2016
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 08/2015
1	Adrenal Gland Neoplasms (Adrenal Cancer) 08/2015
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 08/2015
1	Adrenal Rest Tumor 06/2015
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 06/2015

Drug/Important Bio-Agent (IBA)

15	AldosteroneIBA 01/2022 - 01/2016
9	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022 - 03/2016
7	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 08/2014
6	Hormones (Hormone)IBA 08/2022 - 12/2017
6	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 02/2014
5	SteroidsIBA 01/2021 - 06/2015
4	ParaffinIBA 01/2022 - 08/2016
4	Formaldehyde (Formol)FDA Link 01/2022 - 08/2016
4	Mitotane (Lysodren)FDA Link 06/2015 - 02/2014
3	CatecholaminesIBA 07/2021 - 12/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 11/2021 - 02/2007
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2014
2	EnzymesIBA 01/2021 - 08/2015
2	RNA (Ribonucleic Acid)IBA 08/2020 - 08/2016
2	Messenger RNA (mRNA)IBA 01/2020 - 08/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2009 - 04/2008
1	Capsules (Microcapsules)IBA 08/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	methionyl-aspartyl-phenylalaninamide (MAPN)IBA 01/2022
1	4-hydroxyphenethylene glycolIBA 01/2022
1	Retinaldehyde (Retinal)IBA 11/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2021
1	belzutifanIBA 11/2021
1	3 beta-hydroxysteroid dehydrogenase type IIIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Dehydroepiandrosterone SulfateIBA 11/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020
1	MineralocorticoidsIBA 02/2020
1	ReninIBA 02/2020
1	Sodium Channels (Sodium Channel)IBA 02/2020
1	Ion Channels (Ion Channel)IBA 02/2020
1	Butylated Hydroxyanisole (BHA)IBA 01/2020
1	LipidsIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	trans-sodium crocetinate (crocetin)IBA 07/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019
1	Fumarate Hydratase (Fumarase)IBA 01/2018
1	GastrinsIBA 12/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2017
1	SodiumIBA 07/2017
1	compound 21IBA 06/2015
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 06/2015

Therapy/Procedure

4	Therapeutics 01/2019 - 02/2014
3	Adrenalectomy 03/2022 - 02/2014
2	Radiotherapy 06/2017 - 06/2015
1	Palliative Care (Palliative Therapy) 11/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Thyroidectomy 01/2019